Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Alianza Española de Familias de Von Hippel-Lindau is a Spanish non-profit organization dedicated to supporting patients and families affected by Von Hippel-Lindau (VHL) disease. The alliance focuses on improving the quality of life for those with this rare genetic condition by promoting clinical research and providing essential psychological and social support. They work to establish standardized clinical protocols and advocate for multidisciplinary care in specialized centers across Spain. By collaborating with medical experts and international VHL organizations, the alliance plays a crucial role in advancing the development of new therapies and ensuring early diagnosis for at-risk individuals. Their efforts also include raising public awareness and funding research projects aimed at understanding the molecular mechanisms of VHL-related tumors.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Alianza Española de Familias de Von Hippel-Lindau.